Abstract
Background: Glanzmann thrombasthenia (GT) is an autosomal recessive bleeding disorder characterized by lack of platelet aggregation in response to most physiological agonists and caused by either a lack or dysfunction of the platelet integrin αIIbβ3 (glycoprotein IIb/IIIa). Objectives: To determine the molecular basis of GT and characterize the mutations by in vitro expression studies. Patients: We studied three unrelated patients from southern India whose diagnosis was consistent with GT. Results: Immunoprecipitation of the cell lysates and immunoblotting showed no detectable mature αIIb in the G128S mutant, in contrast to 6% and 33% of the normal amount of mature αIIb in the S287L and G357S mutants, respectively. Pulse-chase analysis demonstrated pro-αIIb in the mutants comparable with the normal pro-αIIb, but no conversion to mature αIIb in the G128S mutant, and only trace conversion to mature αIIb in the S287L and G357S mutants. The disappearance of pro-αIIb in the three mutants was similar to that in cells expressing normal αIIbβ3 or αIIb only. All three mutants demonstrated pro-αIIbβ3 complexes and co-localized with an ER marker by immunofluorescence. The G128S mutant showed no co-localization with a Golgi marker, and the other two mutants showed minimal and moderate co-localization with the Golgi marker. Conclusions: These three β-propeller mutations do not affect the production of pro- αIIb, its ability to complex with β3, or its stability, but do cause variable defects in transport of pro- αIIbβ3 complexes from the endoplasmic reticulum to the Golgi.
Original language | English (US) |
---|---|
Pages (from-to) | 2773-2783 |
Number of pages | 11 |
Journal | Journal of Thrombosis and Haemostasis |
Volume | 3 |
Issue number | 12 |
DOIs | |
State | Published - Dec 2005 |
Externally published | Yes |
Keywords
- Biogenesis
- Glanzmann thrombasthenia
- αβ
- β-propeller mutations
ASJC Scopus subject areas
- Hematology